# Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma

> **NCT03127761** · — · RECRUITING · sponsor: **Center for International Blood and Marrow Transplant Research** · enrollment: 544 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **OTHER:** Allogeneic Hematopoietic Stem Cell Transplant

## Key facts

- **NCT ID:** NCT03127761
- **Lead sponsor:** Center for International Blood and Marrow Transplant Research
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2017-07-25
- **Primary completion:** 2027-05
- **Final completion:** 2028-04
- **Target enrollment:** 544 (ESTIMATED)
- **Last updated:** 2023-08-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03127761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03127761, "Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03127761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*